Biomedical researches is a biomedical research project that emerged at the end of 2013, and its origin is my great passion for biomedical research focused on the cure of serious or incurable diseases.
ULISES PROJECT for pancreatic cancer
(chosen by European Commission in February, 2020)
I'm the author of the original technical project on which the Ulises Project is based, as well as Principal Investigator (PI) of the Ulises Project.
This project is based on a new therapy (immunotherapy) invented by me, by means of delivery of plasmid DNA to transform tumor cells into immunologically incompatible cells, thus provoking the strongest possible attack of the immune system over them, without the use of drugs, chemotherapy, radiotherapy, transplants, etc., thus providing, at the same time, a much better quality of life to the patient, since this new immunotherapy is hoped to cause little or null side effects.
This new immunotherapy is included in my original technical project, which, moreover, includes: immunologic strategy design, genetic design, nanoparticles (including ligands to be used), oncology strategy, biochemistry, Tumor Infiltrating Lymphocytes (TIL) generated around the tumor microenvironment by the immune system, which will lead to an “immunological-memory” avoiding future relapses (vaccine-like effect), "Plans B", etc.
Although Ulises Project is a project for the cure of pancreatic cancer, it's also easily adaptable to any cancer type with minimal changes, and was chosen by the European Commission in February, 2020. It's endowed with a budget of 3 million euros, it started in October, 2020, and its duration will be 3 years.
To make this new immunotherapy a reality I gathered a team of great experts, thus forming an important Consortium containing 10 entities (including me), and belonging to 5 contries (Spain, Germany, Italy, Belgium and The Netherlands).
I am also telecommunications engineer and economist, I work in Telefónica since 1999, in Madrid (Spain), and I am a computer specialist, expert in different programming languages. During the Ulises project, I will be involved in immunology, in order to decide the most optimal immunological setup to be used to improve the immune response over tumor cells. as well as I will also contribute to other areas (genetic design, nanoparticles design, etc.) actively participating in technical and scientific discussions, giving feedback, generating ideas, conducting bibliographic research, contributing to reporting, dissemination and communication of the project results.
We hope our project gets succesfull and the cure of cancer comes a reality as soon as possible.
Here below, in this link, you can see the website of the project:
https://ulises-project.eu/
And we are also in:
ULISES PRESENTATION VIDEO
https://www.youtube.com/watch?v=btrWYZGOzlE
INTERVIEW IN SPANISH TELEVISION (TVE) - CHANNEL "LA 2", PROGRAM "LA AVENTURA DEL SABER", DATE: MAY, 26th, 2021
https://www.rtve.es/alacarta/videos/la-aventura-del-saber/aventura-del-saber-proyecto-ulises-victor-pallaruelo/5917890/
NOTE: My COVID project, because of my full dedication to ULISES project, was ceded initially to VHIR (Vall d'Hebron Institute of Research, in Barcelona, Spain) to be carried out. Unlucky, because of lack of resources, finally, VHIR couldn't carry it out, so that it is currently stopped.
INTERVIEW IN SPANISH RADIO - RADIO 5 (FROM RADIO NACIONAL DE ESPAÑA) - PROGRAM "ENTRE PROBETAS", DATE: JUNE,15th, 2021
https://mediavod-lvlt.rtve.es/resources/TE_SENTREP/mp3/1/0/1623744396801.mp3
(It goes from minute 05:55 to 17:06)
Although I am talking about my biomedical projects (ULISES, Covid), this is a more intimate interview, since it focuses on aspects such as my origins in biomedical research, my future projects, etc...
RADIO 5 (FROM RADIO NACIONAL DE ESPAÑA) - PROGRAM "EL LABORATORIO DE JAL", DATES: SEPTEMBER, 13th, 2021 at 16:22h, and SEPTEMBER, 16th, 2021, at 21:37h
https://mediavod-lvlt.rtve.es/resources/TE_SLABJAL/mp3/6/3/1631520709036.mp3
Scientific pill dedicated to ULISES project, highlighting its most important aspects.